Finance

Beeta
Loendid
Aktsiasektorid
Sรผmbolid
Sรผmbolid
Hind
Muutus
% muutus
Trend
Eelm. sulgemishind
Ava
Kรตrge
Madal
Maht
Turu kapit.
SIXB
Materials
SIXB
Materials
SIXB
โˆ’0,89%
1ย 083,04
โˆ’9,76
โˆ’0,89%
โ€”1ย 092,801ย 093,681ย 094,851ย 081,97โ€”โ€”
SIXC
Communications
SIXC
Communications
SIXC
โˆ’0,39%
602,38
โˆ’2,36
โˆ’0,39%
โ€”604,74604,74605,10601,34โ€”โ€”
SIXE
Energy
SIXE
Energy
SIXE
+2,31%
1ย 242,83
+28,03
+2,31%
โ€”1ย 214,801ย 220,811ย 243,821ย 220,81โ€”โ€”
SIXI
Industrials
SIXI
Industrials
SIXI
โˆ’0,62%
1ย 713,82
โˆ’10,75
โˆ’0,62%
โ€”1ย 724,571ย 727,021ย 732,301ย 707,43โ€”โ€”
SIXM
Financials
SIXM
Financials
SIXM
+0,09%
639,99
+0,56
+0,09%
โ€”639,43641,58644,53637,50โ€”โ€”
SIXR
Staples
SIXR
Staples
SIXR
โˆ’0,20%
837,46
โˆ’1,69
โˆ’0,20%
โ€”839,15836,90840,48832,89โ€”โ€”
SIXRE
Real estate
SIXRE
Real estate
SIXRE
โˆ’0,65%
214,22
โˆ’1,40
โˆ’0,65%
โ€”215,62215,62216,21213,48โ€”โ€”
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3ย 204,38
+24,86
+0,78%
โ€”3ย 179,523ย 191,503ย 205,093ย 177,75โ€”โ€”
SIXU
Utilities
SIXU
Utilities
SIXU
โˆ’1,23%
925,38
โˆ’11,53
โˆ’1,23%
โ€”936,91935,42937,17923,20โ€”โ€”
SIXV
Health care
SIXV
Health care
SIXV
โˆ’0,69%
1ย 442,71
โˆ’10,06
โˆ’0,69%
โ€”1ย 452,771ย 445,931ย 447,431ย 434,91โ€”โ€”
SIXY
Discretionary
SIXY
Discretionary
SIXY
โˆ’0,16%
2ย 361,34
โˆ’3,84
โˆ’0,16%
โ€”2ย 365,182ย 353,642ย 368,102ย 347,80โ€”โ€”
601607:SHA
Shanghai Pharmaceuticals Holding Ord Shs A
17,09ย CNยฅ
+0,95%
(+0,16) 1 p
30. apr, 15:00:02 GMT +8  ·   CNY
Kรตik sรผmbolid
SรผmbolHindMuutus% muutus
รœksuse 601607 pรตhistatistika genereerimineโ€ฆ
Ava
17,00ย CNยฅ
Kรตrge
17,12ย CNยฅ
Madal
16,92ย CNยฅ
Turu kapit.
56,50ย mld
Keskm. maht
10,66ย mln
Maht
11,29ย mln
Hinna ja tulu suhe
11,07
52 nรคd kรตrgeim
19,68ย CNยฅ
52 nรคd madalaim
16,23ย CNยฅ
Aktsiatulu
1,54ย CNยฅ
Kรคibivad aktsiad
1,92ย mld
Tรถรถtajate arv
50ย tuh
Uudised
Erinevatest veebiallikatest
Profiil
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Teave รผksuse Shanghai Pharmaceuticals Holding Ord Shs A kohta
Tegevjuht-
Tรถรถtajad49,6ย tuh
Asutatud18. jaan 1994
Peakontorid-
SektorHealth care provider
Veebisaitpharm-sh.com.cn
Eelmised aruandedKรตik vรครคrtused on valuutas CNY
Loading Previous Earnings...
Kasumiaruanne
Tulu
Netosissetulek
Kรตik vรครคrtused on valuutas CNY
mรคrts 2025
juuni 2025
sept 2025
dets 2025
Tulu
70,76ย mld
70,83ย mld
73,48ย mld
68,51ย mld
Omahind
63,51ย mld
63,12ย mld
66,03ย mld
60,55ย mld
Kogukulu
63,51ย mld
63,12ย mld
66,03ย mld
60,55ย mld
Teadus- ja arenduskulud
497,02ย mln
461,93ย mln
556,53ย mln
824,53ย mln
Kรตik teadus- ja arenduskulud
-
-
-
-
Mรผรผgi-, รผld- ja halduskulud
4,09ย mld
4,70ย mld
4,70ย mld
4,97ย mld
Tegevuskulu
4,98ย mld
5,44ย mld
5,58ย mld
5,91ย mld
Kรตik tegevuskulud
68,48ย mld
68,56ย mld
71,60ย mld
66,47ย mld
Tegevustulu
2,28ย mld
2,27ย mld
1,88ย mld
2,04ย mld
Muu tegevusvรคline tulu
โˆ’14,13ย mln
โˆ’5,42ย mln
โˆ’84,84ย mln
โˆ’63,65ย mln
EBT, sh ebatavalised รผksused
2,15ย mld
4,67ย mld
1,48ย mld
1,52ย mld
EBT, v.a ebatavalised รผksused
2,08ย mld
4,99ย mld
1,61ย mld
1,44ย mld
Tulumaksukulu
512,52ย mln
1,31ย mld
485,91ย mln
534,14ย mln
Kehtiv maksumรครคr
23,81%
28,14%
32,89%
35,10%
Muud tegevuskulud
139,32ย mln
100,05ย mln
129,62ย mln
271,29ย mln
Netosissetulek
1,33ย mld
3,13ย mld
688,20ย mln
577,49ย mln
Puhaskasumi marginaal
1,88%
4,41%
0,94%
0,84%
Aktsiatulu
-
-
-
-
Intressi- ja investeerimistulu
255,23ย mln
3,18ย mld
206,57ย mln
-
Intressikulu
โˆ’444,08ย mln
โˆ’443,61ย mln
โˆ’393,02ย mln
โˆ’470,36ย mln
Netointressikulud
โˆ’188,85ย mln
2,73ย mld
โˆ’186,45ย mln
โˆ’470,36ย mln
Kulum ja amortisatsiooni kulud
-
-
-
-
EBITDA
2,66ย mld
2,74ย mld
2,26ย mld
2,54ย mld
Kasum vรตi kahjum varade mรผรผgist
-
โˆ’39,99ย mln
39,99ย mln
โˆ’157,15ย mln
AI genereeritud sisu vรตib sisaldada vigu. Lisateave
AbiSaada tagasisidetPrivaatsusTingimusedLahtiรผtlus

Uuring

Minu รผlesanded
Te pole veel รผlesannet loonud
Teie รผlesanded kuvatakse siin. Ajastage รผlesanded ja laske Google Finance'il oma eemaloleku ajal tรถรถd teha.
Mallid
Jรคlgimisloendi รผlevaade
Teie jรคlgimisloendi igapรคevane turueelne analรผรผs
Tulevane kasum
Sel nรคdalal avaldatavad kasumiaruanded
Ebatavaline volatiilsus ja maht
Tรคnane volatiilsuse ja mahu eelhoiatus
AI genereeritud sisu vรตib sisaldada vigu. Lisateave
AbiSaada tagasisidetPrivaatsusTingimusedLahtiรผtlus